Search

The coronavirus (COVID-19) pandemic disproportionately affects survivorship outcomes in head and neck cancer (HNC) patients. Perceived threat has been applied to understand vaccination behavior. The purpose of this study was to describe demographic and clinical factors related to the perceived threat of COVID-19 among those undergoing/after HNC treatment. HNC patients who were undergoing or after radiation or chemoradiation were recruited for this cross-sectional study. Participants completed a phone survey that included the Perceived Threat Scale of COVID-19, the Perceived Stress Scale, demographics, COVID-19 screening items, State of Florida COVID-19 screening positive data. Descriptive statistics, Chi Square test, t-test, and multiple regression were performed. Participants (N=30) mean age was 62.5 years (SD=11.1). The most common tumor site was the mouth (37%) and 60% had stage III/IV cancer. The majority underwent chemo-radiation (57%) and had completed treatment (63%). In a multiple regression model, only perceived stress (b=1.20, SE=0.478, t=2.51, p=0.019) and female sex were significant predictors of perceived threat of COVID-19 (b=6.81, SE=2.79, t=2.44, p=0.022). Health messages include threat of COVID-19 should be carefully designed. HNC cancer patients, especially females, who perceived more threat from COVID-19, are those who encountered more stressful emotion. Effective and transparent communication from scientific organizations, public health experts, and media outlets on the safety and efficacy of COVID-19 vaccines should be the focus to promote vaccination behavior. [ABSTRACT FROM AUTHOR]

Lung cancer is the second most common cancer; however, it often is not diagnosed until the advanced stages. Early-stage lung cancer is curable, but screening tools are not usually implemented in practice because of a lack of provider awareness. A lung cancer screening decision aid may increase screening use and, ultimately, reduce lung cancer deaths. At a Glance • Lung cancer screening decreases mortality. • Informed decision making is crucial in optimizing screening. • A majority of prescribers surveyed believe that the lung cancer screening decision aid described in this article is beneficial to their patients. [ABSTRACT FROM AUTHOR]